A Closer Look at RA Treatment: Targeted DMARDs

In this episode, Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman discuss the recent changes in rheumatoid arthritis treatment options, reviewing the landscape of targeted DMARDs and JAK inhibitors, including: Kinase signaling JAK inhibitor activity and signaling JAK selectivity Presenters: Stanley B. Cohen, MDClinical Professor Department of Internal MedicineUniversity of Texas Southwestern Medical SchoolCo-DirectorDivision of RheumatologyPresbyterian HospitalCo-Medical DirectorMetroplex Clinical Research CenterDallas, Texas  Sheetal Desai, MD, MSEdChief of RheumatologyProgram DirectorUniversity of California, IrvineIrvine, California Eric M. Ruderman, MDProfessor, Associate ChiefDivision of RheumatologyNorthwestern University Feinberg School of MedicineClinical Practice DirectorNorthwestern Medical GroupChicago, Illinois Download the accompanying slides at:https://bit.ly/3447Gce See the interactive video at:https://bit.ly/3oCOtpV

2356 232